GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform company
Retrieved on:
Thursday, December 1, 2022
Growth, GSK, Partner, Day Pitney, SDMS, LabCorp, Digital, ESG, ELN, Cros, J&J, Bristol Myers Squibb, Capital, CRS, Laboratory information management system, Informatics, GHO, Francesca De Sapio, Drug development, GMP, Ropes & Gray, Software as a service, LIMS, Pan-European, Drug discovery, Electronic lab notebook, Digital transformation, Fine chemical, Medical device, Pharmaceutical industry, Management, MD
The business is optimally positioned in a high growth market where many incumbent solutions are not fit for purpose.
Key Points:
- The business is optimally positioned in a high growth market where many incumbent solutions are not fit for purpose.
- GHOs support and investment will allow Sapio to explore multiple avenues for growth and expansion for the company, product offering and global footprint.
- The Partners at GHO Capital, said, The trend towards adopting lab informatics solutions is accelerating.
- Sapio provides LIMS, ELN, and Scientific Data Management Solutions through its flexible, scalable, and easy-to-use Seamless Informatics Platform.